Antares Pharma
ATRS
#6030
Rank
HK$7.43 B
Marketcap
HK$43.52
Share price
0.00%
Change (1 day)
27.67%
Change (1 year)

Revenue for Antares Pharma (ATRS)

Revenue in 2021: HK$1.43 Billion

According to Antares Pharma's latest financial reports the company's current revenue (TTM ) is HK$1.43 Billion. In 2021 the company made a revenue of HK$1.43 Billion an increase over the revenue in the year 2020 that were of HK$1.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Antares Pharma from 1996 to 2021

Annual revenue

Year Revenue Change
2021HK$1.43 B22.98%
2020HK$1.16 B20.78%
2019HK$0.96 B94.9%
2018HK$0.49 B16.58%
2017HK$0.42 B4.39%
2016HK$0.40 B14.38%
2015HK$0.35 B72.28%
2014HK$0.20 B28.53%
2013HK$0.16 B-8.67%
2012HK$0.17 B37.17%
2011HK$0.12 B28.39%
2010HK$99.78 M54.24%
2009HK$64.69 M46.82%
2008HK$44.06 M-27.95%
2007HK$61.16 M84.07%
2006HK$33.22 M91.86%
2005HK$17.31 M-18.98%
2004HK$21.37 M-27.49%
2003HK$29.47 M-5.23%
2002HK$31.1 M14.21%
2001HK$27.23 M75.52%
2000HK$15.51 M-42.75%
1999HK$27.1 M26.57%
1998HK$21.41 M-25.99%
1997HK$28.93 M0.68%
1996HK$28.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ANI Pharmaceuticals
ANIP
HK$6.43 B 349.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$166.48 B 11,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
HK$23.49 B 1,540.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Retractable Technologies
RVP
HK$0.29 B-79.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$488.76 B 34,026.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$130.59 B 9,018.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
HK$717.34 B 49,985.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$462.55 B 32,196.53%๐Ÿ‡บ๐Ÿ‡ธ USA